GUT 1998;42:309-311 ( March )

LEADING ARTICLE

Inflammatory bowel disease incidence: up, down or unchanged?

The first 150 words of the full text of this article appear below.

	Introduction

One of the few aspects of the epidemiology of inflammatory bowel disease (IBD) that seems indisputable is the emergence of both ulcerative colitis and Crohn's disease in the economically developed nations of Western Europe and North America during the past century.¹ Some of the apparent increase in incidence undoubtedly reflects a receding tide of mimicking infectious diseases and developments in endoscopic and other diagnostic techniques. Nevertheless, most epidemiologists accept that there were considerable real increases in ulcerative colitis incidence during the first half of this century and of Crohn's disease incidence during the middle half-century in these countries.² As the millennium approaches, are the incidences of each disease continuing to increase? Some reports suggest they are, whereas claims that Crohn's disease incidence is no longer increasing can provoke a rapid response from some clinicians.^3-6 At a time when basic science is making progress by leaps and bounds, why should such . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Fritscher-Ravens, A, Scherbakov, P, Bufler, P, Torroni, F, Ruuska, T, Nuutinen, H, Thomson, M, Tabbers, M, Milla, P (2009). The feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8 years: a multicentre European study. Gut 58: 1467-1472 [Abstract] [Full Text]  
• Browning, B L, Annese, V, Barclay, M L, Bingham, S A, Brand, S, Buning, C, Castro, M, Cucchiara, S, Dallapiccola, B, Drummond, H, Ferguson, L R, Ferraris, A, Fisher, S A, Gearry, R B, Glas, J, Henckaerts, L, Huebner, C, Knafelz, D, Lakatos, L, Lakatos, P L, Latiano, A, Liu, X, Mathew, C, Muller-Myhsok, B, Newman, W G, Nimmo, E R, Noble, C L, Palmieri, O, Parkes, M, Petermann, I, Rutgeerts, P, Satsangi, J, Shelling, A N, Siminovitch, K A, Torok, H-P, Tremelling, M, Vermeire, S, Valvano, M R, Witt, H (2008). Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J. Med. Genet. 45: 36-42 [Abstract] [Full Text]  
• Roberts, S. E, Williams, J. G, Yeates, D., Goldacre, M. J (2007). Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 335: 1033-1033 [Abstract] [Full Text]  
• (2007). Abstracts. Gut 56: a1-a145 [Full Text]  
• Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full Text]  
• Ahmed, M, Davies, I H, Hood, K, Jenkins, H R (2006). Incidence of paediatric inflammatory bowel disease in South Wales.. Arch. Dis. Child. 91: 344-345 [Full Text]  
• Otani, T., Yamaguchi, K., Scherl, E., Du, B., Tai, H.-H., Greifer, M., Petrovic, L., Daikoku, T., Dey, S. K., Subbaramaiah, K., Dannenberg, A. J. (2006). Levels of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-{alpha}. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G361-G368 [Abstract] [Full Text]  
• Andreyev, J (2005). Gastrointestinal complications of pelvic radiotherapy: are they of any importance?. Gut 54: 1051-1054 [Abstract] [Full Text]  
• Bassi, A, Dodd, S, Williamson, P, Bodger, K (2004). Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53: 1471-1478 [Abstract] [Full Text]  
• Subbaramaiah, K., Yoshimatsu, K., Scherl, E., Das, K. M., Glazier, K. D., Golijanin, D., Soslow, R. A., Tanabe, T., Naraba, H., Dannenberg, A. J. (2004). Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease: EVIDENCE FOR INVOLVEMENT OF THE TRANSCRIPTION FACTOR Egr-1. J. Biol. Chem. 279: 12647-12658 [Abstract] [Full Text]  
• Card, T, Logan, R F A, Rodrigues, L C, Wheeler, J G (2004). Antibiotic use and the development of Crohn's disease. Gut 53: 246-250 [Abstract] [Full Text]  
• Seagroatt, V, Goldacre, M J (2003). Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998. J. Epidemiol. Community Health 57: 883-887 [Abstract] [Full Text]  
• Hildebrand, H, Finkel, Y, Grahnquist, L, Lindholm, J, Ekbom, A, Askling, J (2003). Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 52: 1432-1434 [Abstract] [Full Text]  
• Hart, M. H. (2002). Inflammatory Bowel Disease in Infants and Young Children. AAP Grand Rounds 8: 54-55 [Full Text]  
• Loftus, E V Jr, Silverstein, M D, Sandborn, W J, Tremaine, W J, Harmsen, W S, Zinsmeister, A R (2000). Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 46: 336-343 [Abstract] [Full Text]  
• ALIC, M (2000). The role of psychological and biological factors in postinfective gut dysfunction.. Gut 46: 140-141 [Full Text]